Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Access to healthcare

The fight against malaria

For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.

Our Community

Victoria Police - Trek of a lifetime

We have been a long-standing supporter of the Victoria Police Kokoda Project, supporting the initiative since it began in 2007.

Access to healthcare

No 'silver bullet' to tackle this disease

Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.

Our Community

Keeping our Olympic athletes healthy and ready to compete in Rio

GSK is supplying the Australian Olympics Team with vaccines to protect them against everyday illnesses ahead of the games in Rio.

How we do business

PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines

The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.

Our Community

A comic book on vaccines

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.